Milnacipran: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Milnacipran. Educational only — not medical advice.

Labeled uses

Milnacipran hydrochloride tablets are indicated for the management of fibromyalgia. Milnacipran hydrochloride tablets are not approved for use in pediatric patients [see Use in Specific Populations (8.4 )].

Source: FDA labeling via NIH DailyMed (set 52ad5462…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.

Compare lab testing options near you ↗ (affiliate link)